Somerset Indus Capital Partners

Somerset Indus Capital Partners

Signal active

Investment Firm

Overview

Somerset Indus Capital Partners seeks to make private equity and equity-related investments primarily in growth-oriented healthcare companies in India. Somerset is led by Avinash Kenkare on the offshore fund side, a private equity professional with eighteen years of successful investing experience in over fifteen transactions, and duly assisted by Mayur Sirdesai on domestic fund side, a healthcare professional with over twenty years of experience in the Indian Pharma/ Healthcare Industry with both private equity, operational and consulting services related experience.

Highlights

Founded

2011

Industry

Employees

1-10

Investment

13

Lead Investment

7

Exits

1

Stages

Seed, Early Stage Venture, Private Equity

Investor Type

Private Equity Firm

Location

Africa

Contact Information

Social

Profile Resume

Somerset Indus Capital Partners, established in 2011 and headquartered in Africa., specializes in Seed, Early Stage Venture, Private Equity investments across Health Care, Medical, Medical Device, Hospital, Food and Beverage, Pharmaceutical, Fitness, Manufacturing, Wellness, Nutrition. The organization boasts a portfolio of 12 investments, with an average round size of $6.2M and 1 successful exits. Their recent investments include Browndove Healthcare, Hexagon Nutrition, Genworks, Zawawi Group, Printmann Group. The highest investment round they participated in was $1.1B. Among their most notable exits are Browndove Healthcare and Hexagon Nutrition. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.

Employees

imagePlace Avinash Kenkare

Avinash Kenkare

Partner

imagePlace Mayur Sirdesai

Mayur Sirdesai

Partner and Founder

Investment portfolio

Somerset Indus Capital Partners has made 13 investments. Their most recent investment was on Aug 09, 2024, when Genworks raised $4.9M.

investments

13

Diversity investments

0

Lead investments

7

Number of exits

1

Investments

13

Annouced DateOrganization NameIndustryMoney Raised
May 04, 2022
Genworks Genworks
Information Technology17.8M
Apr 25, 2023
Emil Pharmaceutical Emil Pharmaceutical
Pharmaceutical14.6M
Feb 13, 2024
Printmann Group Printmann Group
Manufacturingnull
Aug 09, 2024
Genworks Genworks
Information Technology4.9M

Exits

1

Funding Timeline

Funding rounds

13

Investors

0

Funds

0

Funding Rounds

13

Somerset Indus Capital Partners has raised 13 rounds. Their latest funding was raised on Aug 09, 2024 from a Venture Round - Genworks round.

Annouced DateTransaction NameNumber of InvestorsMoney RaisedLead Investor
May 04, 2022
Venture Round - Genworks Venture Round - Genworks
-17.8M-
Apr 25, 2023
Private Equity Round - Emil Pharmaceutical Private Equity Round - Emil Pharmaceutical
-14.6M-
Feb 13, 2024
Private Equity Round - Printmann Group Private Equity Round - Printmann Group
-0-
Aug 09, 2024
Venture Round - Genworks Venture Round - Genworks
-4.9M-

Investors

0

There is no funding round available on this profile

Fund raised

2

Susa Ventures has raised a total of $590M across 6 funds, their latest being Susa Ventures Opportunities II. This fund was announced on Aug 30, 2021 and raised a total of $250M.

Annouced DateFund NameMoney Raised
May 10, 2013
fund image OTPPLESS
1.0M
May 11, 2013
fund image OTPPLESS
1.0M

Invest in industries

N/A

Recent Activity

There is no recent news or activity for this profile.